Arthur H. Tavares

Arthur H. Tavares

Auto-generated profile, based on publicly available information

Arthur H. Tavares

Universidade de Pernambuco, Departamento de Medicina, Recife, PE, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2023 in Energy Policy
Verified
Journal Article
Closed access
CGCarolina Grangeia
Carolina Grangeia
LSLuan Santos
Luan Santos
DFDaniel Viana Ferreira
Daniel Viana Ferreira
RGRaphael Guimarães
Raphael Guimarães
LOLuiz de Magalhães Ozorio
Luiz de Magalhães Ozorio
ATArthur Tavares
Arthur Tavares

10 June 2025 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
Vitor FelippeVitor Felippe
Vitor Felippe
APAna C. Pinho
Ana C. Pinho
LBLucas M. Barbosa
Lucas M. Barbosa
IQIvo Queiroz
Ivo Queiroz
ATArthur H. Tavares
Arthur H. Tavares
JVJean-Louis Vincent
Jean-Louis Vincent
The efficacy of the Hypotension Prediction Index (HPI) for reducing Intraoperative Hypotension (IOH) among patients undergoing non-cardiac surgeries remains unclear. We aimed to perform a systematic review, meta-analysis, and trial sequential analysis to determine whether the HPI is effective for adult patients undergoing non-cardiac surgeries. This study was prospectively registered in the PROSPERO database (CRD42024571931). PubMed, Embase, and Cochrane were systematically searched for Randomized Controlled Trials (RCTs) comparing HPI-guided therapy with standard care in non-cardiac surgeries. We computed Mean Difference (MD) and Risk Ratios (RR) for continuous and binary outcomes, respectively, with 95 % Confidence Intervals (95 % CI). Statistical analyses were performed using R Software, version 4.2.3. We included 11 RCTs, comprising a total of 789 patients, of whom 395 (50.1 %) received HPI-guided management. HPI significantly reduced the Time-Weighted Average (TWA) of Mean Arterial Pressure (MAP) < 65 mmHg (MD = -0.23 mmHg.min-1; 95 % CI -0.35 to -0.10; p < 0.01) and the Area Under the Curve (AUC) of MAP < 65 mmHg (MD = -97.2 mmHg.min-1; 95 % CI -143.4 to -50.98; p < 0.01). HPI also decreased the duration of MAP < 65 mmHg (MD = -16.22 min; 95 % CI -25.87 to -6.57; p < 0.01) and the number of hypotensive episodes per patient (MD = -3.38; 95 % CI -5.38 to -1.37; p < 0.01). No significant differences were observed in the number of hypotensive events, phenylephrine use, or AKI incidence (p > 0.05). In adult patients undergoing non-cardiac surgeries, HPI use was associated with a reduction in the duration and severity of IOH, with no significant difference for adverse events. Limitations include significant heterogeneity across studies, differences in HPI implementation, and lack of long-term outcome data.